areas of business | location | contact

Founded by eminent global pharma executives and promoted by the Tata Group, Advinus Therapeutics is a research-based pharmaceutical company. Set up with an investment of $35 million (Rs160 crore), the company is the first of its kind in India to offer end-to-end development services to the global pharma, agro and biotech industry.

Areas of business
Advinus has two business units. One focuses on drug discovery in Pune. It aims to generate its own drug candidates with the objective of out-licensing them at preclinical or clinical stage. The company's drug discovery efforts are focused in metabolic and inflammatory diseases. Towards this end, Advinus has tied up with Merck — one of the largest and most respected global pharma companies — for discovery and development of novel therapies for multiple targets in the area of metabolic diseases.

The other business unit, based in Bangalore, focuses on development and offers end-to-end preclinical to early clinical development platform for biotech, pharma and agro-chemical industries. The centre supports and supplements the client resources in the areas of process development, drug metabolism and pharmacokinetics, clinical pharmacology, safety assessment, formulation development and analytical R&D.

One of the most accredited R&D centres in India, it has certification from AAALAC International and the German, Dutch and Indian authorities for GLP compliance. All data generated by the centre is 21 CFR part 11 compliant.

Advinus also has an interest in pursuing the discovery of novel therapies for neglected or developing world diseases such as malaria and dengue, to address the unfulfilled need in developing nations for safe, effective and affordable therapy.

Location
Advinus has one drug discovery centre with a state-of-the-art facility at the Biotech Park in Hinjewadi, Pune and another development centre at an 8-acre campus in Bangalore.

Contact
Advinus Therapeutics
21 & 22, Phase II
Peenya Industrial Area
Bangalore 560 058
India
Phone: +91 (80) 2839 4959 (Board)
Fax: +91 (80) 2839 4015